Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Small Intestine Cancer
NCT00003522Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Aug 1997
- Primary completion
- Dec 1997
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in small intestine carcinoma, sponsored by Burzynski Research Institute. Started Aug 1997; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
small intestine carcinoma
Beyond the preview
Go deeper on NCT00003522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003522.